Article
Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death.
Thrombosis and haemostasis - 1 Mar 2000
Zotz R B, Klein M, Dauben H P, Moser C, Gams E, Scharf R E
Abstract excerpt
Recently, we have demonstrated that human platelet antigen 1b (HPA-1b or P1A2) is a hereditary risk factor for platelet thrombogenicity leading to premature myocardial infarction in preexisting coronary artery disease. However, HPA-lb does not represent a risk factor for coronary artery disease itself. The aim of our present study was to evaluate the role of HPA-lb on the outcome in patients after coronary-artery...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
